143 related articles for article (PubMed ID: 19498459)
1. Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis.
Zheng JN; Pei DS; Mao LJ; Liu XY; Sun FH; Zhang BF; Liu YQ; Liu JJ; Li W; Han D
Cancer Gene Ther; 2010 Jan; 17(1):28-36. PubMed ID: 19498459
[TBL] [Abstract][Full Text] [Related]
2. Potent antitumor efficacy of interleukin-18 delivered by conditionally replicative adenovirus vector in renal cell carcinoma-bearing nude mice via inhibition of angiogenesis.
Zheng JN; Pei DS; Sun FH; Liu XY; Mao LJ; Zhang BF; Wen RM; Xu W; Shi Z; Liu JJ; Li W
Cancer Biol Ther; 2009 Apr; 8(7):599-606. PubMed ID: 19305163
[TBL] [Abstract][Full Text] [Related]
3. Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.
Zhao L; Gu J; Dong A; Zhang Y; Zhong L; He L; Wang Y; Zhang J; Zhang Z; Huiwang J; Qian Q; Qian C; Liu X
Hum Gene Ther; 2005 Jul; 16(7):845-58. PubMed ID: 16000066
[TBL] [Abstract][Full Text] [Related]
4. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.
Zhao L; Dong A; Gu J; Liu Z; Zhang Y; Zhang W; Wang Y; He L; Qian C; Qian Q; Liu X
Cancer Gene Ther; 2006 Nov; 13(11):1011-22. PubMed ID: 16799468
[TBL] [Abstract][Full Text] [Related]
5. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
Zhang Y; Gu J; Zhao L; He L; Qian W; Wang J; Wang Y; Qian Q; Qian C; Wu J; Liu XY
Cancer Res; 2006 Apr; 66(8):4291-8. PubMed ID: 16618754
[TBL] [Abstract][Full Text] [Related]
6. Synergistic antitumor effect of TRAIL and IL-24 with complete eradication of hepatoma in the CTGVT-DG strategy.
Cai Y; Liu X; Huang W; Zhang K; Liu XY
Acta Biochim Biophys Sin (Shanghai); 2012 Jun; 44(6):535-43. PubMed ID: 22635106
[TBL] [Abstract][Full Text] [Related]
7. Potent antitumor efficacy of ST13 for colorectal cancer mediated by oncolytic adenovirus via mitochondrial apoptotic cell death.
Yang M; Cao X; Yu MC; Gu JF; Shen ZH; Ding M; Yu DB; Zheng S; Liu Xy
Hum Gene Ther; 2008 Apr; 19(4):343-53. PubMed ID: 18355116
[TBL] [Abstract][Full Text] [Related]
8. Potent anti-tumour activity of a novel conditionally replicating adenovirus for melanoma via inhibition of migration and invasion.
Jiang G; Yang CS; Xu D; Sun C; Zheng JN; Lei TC; Liu YQ
Br J Cancer; 2014 May; 110(10):2496-505. PubMed ID: 24714752
[TBL] [Abstract][Full Text] [Related]
9. An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer.
Zhong S; Yu D; Wang Y; Qiu S; Wu S; Liu XY
Acta Oncol; 2010; 49(1):91-9. PubMed ID: 19734998
[TBL] [Abstract][Full Text] [Related]
10. Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis.
Jiang G; Liu YQ; Wei ZP; Pei DS; Mao LJ; Zheng JN
Cancer Lett; 2010 Aug; 294(2):220-8. PubMed ID: 20189296
[TBL] [Abstract][Full Text] [Related]
11. Enhanced in-vitro and in-vivo suppression of A375 melanoma by combined IL-24/OSM adenoviral-mediated gene therapy.
Xu Y; Zhang F; Qin L; Miao J; Sheng W; Xie Y; Xu X; Yang J; Qian H
Melanoma Res; 2014 Feb; 24(1):20-31. PubMed ID: 24300090
[TBL] [Abstract][Full Text] [Related]
12. [Mechanisms of enhanced antileukemia activity of conditionally replicating adenovirus (CRAd) ZD55 by interleukin-24].
Liu JQ; Yang CM; Ding W; Qian WB
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 May; 39(3):231-5. PubMed ID: 20544982
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo.
Jiang G; Sun C; Li RH; Wei ZP; Zheng JN; Liu YQ
J Cancer Res Clin Oncol; 2015 Jan; 141(1):75-85. PubMed ID: 25103017
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil.
Chu L; Gu J; Sun L; Qian Q; Qian C; Liu X
Gene Ther; 2008 Apr; 15(7):484-94. PubMed ID: 18239605
[TBL] [Abstract][Full Text] [Related]
15. Significant antitumor activity of oncolytic adenovirus expressing human interferon-beta for hepatocellular carcinoma.
He LF; Gu JF; Tang WH; Fan JK; Wei N; Zou WG; Zhang YH; Zhao LL; Liu XY
J Gene Med; 2008 Sep; 10(9):983-92. PubMed ID: 18618506
[TBL] [Abstract][Full Text] [Related]
16. Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL.
Liu X; Cao X; Wei R; Cai Y; Li H; Gui J; Zhong D; Liu XY; Huang K
Cancer Gene Ther; 2012 Jan; 19(1):49-57. PubMed ID: 21979578
[TBL] [Abstract][Full Text] [Related]
17. VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis.
Xiao T; Fan JK; Huang HL; Gu JF; Li LY; Liu XY
Cell Res; 2010 Mar; 20(3):367-78. PubMed ID: 19918267
[TBL] [Abstract][Full Text] [Related]
18. Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition.
Yoo JY; Kim JH; Kim J; Huang JH; Zhang SN; Kang YA; Kim H; Yun CO
Gene Ther; 2008 May; 15(9):635-51. PubMed ID: 18273054
[TBL] [Abstract][Full Text] [Related]
19. Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus.
Yang Y; Xu H; Huang W; Ding M; Xiao J; Yang D; Li H; Liu XY; Chu L
J Cell Mol Med; 2015 May; 19(5):915-23. PubMed ID: 25683371
[TBL] [Abstract][Full Text] [Related]
20. Targeting gene-virotherapy of cancer and its prosperity.
Liu XY
Cell Res; 2006 Nov; 16(11):879-86. PubMed ID: 17102812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
